Skip to main content
. 2015 Oct 15;3(4):373–389. doi: 10.3390/toxics3040373

Table 2.

Effect of haloxyfop-p methyl ester on plasma biomarkers of hepatic function in rat.

Treatment groups Bilirubin (mg/dL) ALP (U/L) ALT (U/L) AST (U/L)
0 (Control) 0.29 ± 0.01 262.8 ± 8.6 30.4 ± 3.1 61.2 ± 5.6
6.75 mg/kg bw HPME 0.37 ± 0.01 (28%) * 355.4 ± 9.1 (35%) * 36.0 ± 2.6 (18%) * 66.4 ± 4.1 (8%) *
13.50 mg/kg bw HPME 0.47 ± 0.02 (62%) * 384.2 ± 6.6 (46%) * 41.1 ± 2.3 (35%) * 73.4 ± 5.1 (20%) *
27.00 mg/kg bw HPME 0.57 ± 0.01 (97%) * 438.8 ± 7.4 (67%) * 45.2 ± 3.6 (49%) * 77.0 ± 2.7 (26%) *

Values are the means ± SD for six replicates; * values significantly different from the control at p ˂ 0.05; values in parenthesis represent the percentage (%) increase compared to the control.